Conduit Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $750,157 | $696,375 | $2,715,194 | $698,221 |
Gross Profit | 301,031 | 258,088 | -515 | -885 |
EBITDA | 159,656 | 108,686 | -18,878 | -6,185 |
EBIT | 127,200 | 76,230 | -21,287 | -7,070 |
Net Income | 68,536 | 51,027 | -21,325 | -7,118 |
Net Change In Cash | 750,157 | 696,375 | 2,715,194 | 698,221 |
Free Cash Flow | 2,080 | -63,058 | -5,641 | 65,325 |
Cash | 348,655 | 272,151 | 389,887 | 3,838 |
Basic Shares | 39,338 | 393 | 921 | 540 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,715,194 | $922,222 | $0 | $0 |
Gross Profit | 1,031,172 | -457 | ||
EBITDA | -36,480 | -15,839 | 3,053 | -4,887 |
EBIT | -38,905 | -16,296 | -324 | -3,160 |
Net Income | -39,224 | -17,802 | -535 | -4,887 |
Net Change In Cash | 2,715,194 | 922,222 | 0 | 0 |
Free Cash Flow | -17,958 | -9,733 | -7,725 | -2,266 |
Cash | 389,887 | 554 | 4,228 | 345 |
Basic Shares | 333 | 7 | 5 | 1 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$5.56 |
2026-03-31 | -$99.99 |
2025-12-31 | -$2,314.41 |
2025-09-30 | -$13.16 |